These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38406549)

  • 1. Atypical meningeal localization of classical hairy cell leukemia with an impressive response to rituximab and cladribine association. A case report and literature review.
    Claves F; Carras S; Burroni B; Maitre E; Boutonnat J; Troussard X; Molina L
    EJHaem; 2024 Feb; 5(1):242-246. PubMed ID: 38406549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: A case of classic hairy cell leukemia with CNS involvement treated with vemurafenib.
    Johnson AE; Raju AR; Jacob A; Hildebrandt GC
    Front Oncol; 2022; 12():1100577. PubMed ID: 36713531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of patients with hairy cell leukemia in the south of Iran.
    Dehghani M; Kashkooe A; Namdari N; Majidi R; Karimi M; Haghighat S; Rezvani A; Safari N
    Expert Rev Hematol; 2023 Apr; 16(4):289-295. PubMed ID: 36709461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.
    Chihara D; Kantarjian H; O'Brien S; Jorgensen J; Pierce S; Faderl S; Ferrajoli A; Poku R; Jain P; Thompson P; Brandt M; Luthra R; Burger J; Keating M; Ravandi F
    Br J Haematol; 2016 Sep; 174(5):760-6. PubMed ID: 27301277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia.
    Chihara D; Arons E; Stetler-Stevenson M; Yuan CM; Wang HW; Zhou H; Raffeld M; Xi L; Steinberg SM; Feurtado J; James L; Wilson W; Braylan RC; Calvo KR; Maric I; Dulau-Florea A; Kreitman RJ
    J Clin Oncol; 2020 May; 38(14):1527-1538. PubMed ID: 32109194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab in the treatment of the variant of hairy cell leukaemia: a case report.
    Hadzi-Pecova L; Stojanovik A; Petrusevska G; Panovska I
    Prilozi; 2008 Dec; 29(2):355-60. PubMed ID: 19259059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bullous Pyoderma Gangrenosum Associated with Hairy Cell Leukemia and Its Complete Response to Cladribine Therapy.
    Jain A; Lad D; Prakash G; Khadwal A; Malhotra P; Bal A; Mallik N; Kumar N; Varma S
    Indian J Hematol Blood Transfus; 2017 Jun; 33(2):273-275. PubMed ID: 28596664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of 24 patients of hairy cell leukemia treated by cladribine].
    Wang TY; Li ZJ; Lyu R; Fu MW; Sui WW; Huang WY; Liu W; An G; Deng SH; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):491-495. PubMed ID: 30032567
    [No Abstract]   [Full Text] [Related]  

  • 9. My treatment approach to hairy cell leukemia.
    Naik RR; Saven A
    Mayo Clin Proc; 2012 Jan; 87(1):67-76. PubMed ID: 22212971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful induction of long-term remission using rituximab in a patient with refractory hairy cell leukemia-Japanese variant.
    Imamura T; Ohtsuka E; Ogata M; Oka F; Kashima K; Kikuchi H; Nasu M
    Int J Hematol; 2004 Dec; 80(5):432-4. PubMed ID: 15646655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hairy cell leukemia-variant with cladribine.
    Tetreault SA; Robbins BA; Saven A
    Leuk Lymphoma; 1999 Oct; 35(3-4):347-54. PubMed ID: 10706459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitantly Diagnosed Disseminated
    Stanton DJ; Quadri NZ; Tanabe MB
    J Investig Med High Impact Case Rep; 2024; 12():23247096241253343. PubMed ID: 38767131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence.
    Else M; Dearden CE; Matutes E; Forconi F; Lauria F; Ahmad H; Kelly S; Liyanage A; Ratnayake V; Shankari J; Whalley I; Catovsky D
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():75-8. PubMed ID: 21504288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Outcomes Of Patients With Hairy Cell Leukaemia; A 16-Year Experience At A Tertiary Care Center In Pakistan.
    Yousaf M; Khan MA; Iftikhar R; Chaudary QU; Shahbaz N; Ahmad U; Javed H
    J Ayub Med Coll Abbottabad; 2022; 34(4):797-801. PubMed ID: 36566402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous or Metachronous Hairy Cell Leukemia and Chronic Lymphocytic Leukemia: A Case Series and Literature Review.
    Verma V; Giri S; Bhatt VR; Amador-Ortiz C; Armitage JO
    Front Oncol; 2016; 6():270. PubMed ID: 28119853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacological management of hairy cell leukemia.
    Ramos Perez J; Ravandi-Kashani F
    Expert Opin Pharmacother; 2020 Aug; 21(11):1337-1344. PubMed ID: 32378970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
    Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
    Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia.
    Nieva J; Bethel K; Saven A
    Blood; 2003 Aug; 102(3):810-3. PubMed ID: 12663446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and molecular characteristics and prognosis of classical hairy cell leukemia and hairy cell leukemia variant].
    Wei C; Jin XX; Cai H; Wang X; Zhuang JL; Zhou DB
    Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):416-421. PubMed ID: 37032137
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia.
    Marvin-Peek J; Jen WY; Kantarjian HM; McCue D; Haddad FG; Wierda W; Ferrajoli A; Burger J; Abusab T; Jorgensen J; Wang SA; Patel K; Loghavi S; O'Brien S; Ravandi F
    Leuk Lymphoma; 2024 Sep; 65(9):1325-1334. PubMed ID: 38749022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.